pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,831
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Phase 3
navitoclax dihydrochloride
navitoclax dihydrochloride
Myelofibrosis
$ABBV
AbbVie Inc.
Phase 2
navtemadlin
navtemadlin
Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
Kartos Therapeutics Inc
Phase 2
naxitamab
Danyelza (naxitamab-gqgk)
Neuroblastoma
Y-mAbs Therapeutics Inc
Phase 3
← prev
page 52 of 62
next →
Pain
89
Neurology
1
naxtarubicin
naxtarubicin
Refractory Acute Myeloid Leukemia
$MBRX
Moleculin Biotech, Inc.
Marketed
necitumumab
Portrazza (necitumumab)
Squamous Non-Small Cell Lung Cancer
Eli Lilly and Co
Preclinical
nedaplatin
nedaplatin [INN]
Esophageal Cancer
RNR BioMedical Inc
pre_registration
neladalkib
neladalkib
Non-Small Cell Lung Cancer
$NUVL
Nuvalent, Inc.
Phase 1
neldaleucel
neldaleucel
Chronic Lymphocytic Leukemia (CLL)
$MRKR
Marker Therapeutics, Inc.
Phase 2
nemtabrutinib
nemtabrutinib
Follicular Lymphoma
$MRK
Merck & Co., Inc.
Marketed
neratinib
Nerlynx (neratinib)
Metastatic Brain Tumor
$PBYI
PUMA BIOTECHNOLOGY, INC.
Phase 2
nesuparib
nesuparib [INN]
Pancreatic Ductal Adenocarcinoma
Onconic Therapeutics Co Ltd
Phase 3
nibrozetone
nibrozetone
Small-Cell Lung Cancer
EpicentRx Inc
Marketed
nilutamide
Nilutamide Prasco (nilutamide)
Metastatic Prostate Cancer
Prasco LLC
Phase 2
ninsipapogene sibarnarepvec
ninsipapogene sibarnarepvec
Head And Neck Squamous Cell Carcinoma (HNSC)
$HOOK
HOOKIPA Pharma Inc.
Phase 2
nitroxoline
nitroxoline [INN]
Muscle Invasive Bladder Cancer (MIBC)
Asieris Pharmaceuticals (USA) Inc
Phase 3
nivolumab biosimilar
Bladder Cancer
Xbrane Biopharma AB
Phase 3
nofazinlimab
nofazinlimab [INN]
Hepatocellular Carcinoma
CStone Pharmaceuticals Co Ltd
pre_registration
nogapendekin alfa
Anktiva (nogapendekin alfa)
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial B…
$IBRX
ImmunityBio, Inc.
Phase 2
nuvisertib hydrochloride
nuvisertib hydrochloride
Secondary Myelofibrosis
Sumitomo Pharma America Inc
Phase 2
nuzefatide pevedotin
nuzefatide pevedotin [INN]
Gastric Cancer
$BCYC
BICYCLE THERAPEUTICS PLC
Phase 3
obecabtagene autoleucel
Aucatzyl (obecabtagene autoleucel)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…
$AUTL
Autolus Therapeutics plc
Phase 1
oberotatug ravtansine
oberotatug ravtansine
Adenoid Cystic Carcinoma (ACC)
Oxford BioTherapeutics Ltd
Phase 2
obrixtamig
obrixtamig [INN]
Small-Cell Lung Cancer
Boehringer Ingelheim International GmbH
Phase 2
ocifisertib
ocifisertib [INN]
Refractory Acute Myeloid Leukemia
Treadwell Therapeutics Inc
pre_registration
octreotide LA
Oclaiz (octreotide)
Acromegaly
Camurus AB
Phase 2
odafosfamide
odafosfamide [INN]
T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphobla…
OBI Pharma Inc
Phase 3
odronextamab
odronextamab
Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associat…
$REGN
REGENERON PHARMACEUTICALS, INC.
Phase 2
olafertinib
olafertinib [INN]
Non-Small Cell Lung Cancer
Checkpoint Therapeutics Inc
Phase 2
olaptesed pegol
olaptesed pegol [INN]
Glioblastoma Multiforme (GBM)
TME Pharma AG
Phase 3
olomorasib
olomorasib
Non-Small Cell Lung Cancer
Eli Lilly and Co
